← Back to news
Y

Yahoo Finance

Chartwell Retirement Residences Q4 Earnings Call Highlights

Y

Cargojet Q4 Earnings Call Highlights

Y

Canadian Utilities Q4 Earnings Call Highlights

Y

Chemtrade Logistics Income Fund Q4 Earnings Call Highlights

Y

What to know about Trump’s new student loan repayment plan

Y

Household debt is crushing Americans. Here's what to do

Y

Pearson plc (PSO) Announces Preliminary Fiscal 2025 Results

Y

Mizuho Lowers PT on Willis Towers Watson (WTW), Keeps a Buy Rating

Y

RBC Capital Maintains a Hold Rating on Rio Tinto Group (RIO)

Y

Nomad Foods (NOMD) Down 11% Since Q4 2025 Results

Y

Brightstar Lottery PLC (BRSL) Releases Q4 2025 Results, Here’s What You Should Know

Y

IHS Holding Limited (IHS) Announces its Merger Agreement With MTN Group

Y

Marex Group (MRX) Acquires Webb Traders to Boost Trading Capability

Y

WPP Plc (WPP) Announces its Multi-Year Strategic Plan, Here’s What You Need to Know

Y

Janus Henderson (JHG) Launches Janus Henderson AA‑A CLO ETF

Y

NatWest Group plc (NWG) Hires Ruari Phillips as Head of Venture & Growth Finance

Y

UBS Remains a Buy on Barclays PLC (BCS)

Y

UBS Remains a Buy on British American Tobacco (BTI)

Y

JPMorgan Raises PT on Shell plc (SHEL), Here’s Why

Y

Oil Markets Face Iran Conflict With Little in Reserve

Y

Buy 2 Vanguard Index Funds to Beat the S&P 500 in the Next 5 Years, According to Wall Street Analysts

Y

Is This 1 Number Nvidia's Biggest Risk?

Y

401(k) Contribution Rates Explained: How Do You Compare to Other Savers

Y

JPMorgan Lifts PT on Equinor ASA (EQNR) to NOK 240 From NOK 220

Y

BofA Lifts PT on Kinross Gold Corporation (KGC) to $42.75 from $37.50, Here’s Why

Y

Wells Fargo Lifts PT on Keurig Dr. Pepper Inc. (KDP) to $40 from $35 – Here’s Why

Y

Vale S.A. (VALE) Gets Downgraded to Neutral from Buy by BofA, Here’s Why

Y

Grupo Santander Downgrades BP p.l.c. (BP) to Neutral from Outperform

Y

Novo Nordisk A/S (NVO) Announces FDA Approval of Three New Indications for Sogroya

Y

Pfizer Inc. (PFE) and Astellas Pharma Announce Positive Results From the Phase 3 EV-304 Clinical Trial for PADCEVTM

Y

Why Eni S.p.A. (E) is One of the Best Cheap Stocks Under $50 to Buy Right Now

Y

Cantor Fitzgerald Lifts PT on Innoviva, Inc. (INVA) to $32 from $31 – Here’s Why

Y

Guggenheim Raises PT on Phathom Pharmaceuticals (PHAT) to $25 From $20, Here’s Why

Y

Is Halozyme Therapeutics (HALO) a Buy Post Earnings?

Y

Aurinia Pharmaceuticals (AUPH) Reports Financial Results for Three and Twelve Months Ended December 31, 2025

Y

Catalyst Pharmaceuticals (CPRX) Reports Record Q4 and Full Year 2025 Results

Y

Wells Fargo Cuts PT on Sarepta Therapeutics (SRPT) to $38 From $45

Y

Deutsche Bank Cuts PT on Harmony Biosciences Holdings (HRMY) to $30 From $31

Y

TD Cowen Lifts PT on Royalty Pharma Plc (RPRX) to $50 from $45, Here’s Why

Y

TG Therapeutics (TGTX) Reports Financial Results for Q4 and Full Year 2025

Y

Wells Fargo Cuts PT on Soleno Therapeutics (SLNO) to $110 From $114 – Here’s Why

Y

Canaccord Lifts PT on BioMarin Pharmaceutical (BMRN) to $104 From $98 – Here’s Why

Y

Is Jazz Pharmaceuticals (JAZZ) One of the Best Cheap Biotech Stocks to Buy Now?

Y

Is the Trump Bull Market on Its Last Leg? 4 Historically Accurate Indicators Offer a Clear Answer.

Y

Analyst Sentiment on SS&C Technologies (SSNC) Remains Strong Despite Lingering AI Risks

Y

Truist Analysts Mixed on EPAM Systems (EPAM) Despite Revenue, Operating Income Beat

Y

Jefferies Bullish on ICON (ICLR) Despite Share Price Decline

Y

Leidos Holdings (LDOS) Advances Operations as Terminal Flight Data Manager System Goes Live At Reagan National Airport

Y

Cascades Q4 Earnings Call Highlights

Y

BTB Real Estate Investment Trust Q4 Earnings Call Highlights

Y